Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm.

Perez CA, Ott J, Mays DJ, Pietenpol JA.

Oncogene. 2007 Nov 15;26(52):7363-70. Epub 2007 Jun 11.

PMID:
17563751
[PubMed - indexed for MEDLINE]
2.

Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.

Ortt K, Sinha S.

FEBS Lett. 2006 Aug 7;580(18):4544-50. Epub 2006 Jul 25.

PMID:
16870177
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential recognition of response elements determines target gene specificity for p53 and p63.

Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D.

Mol Cell Biol. 2005 Jul;25(14):6077-89.

PMID:
15988020
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53.

Klein C, Georges G, Künkele KP, Huber R, Engh RA, Hansen S.

J Biol Chem. 2001 Oct 5;276(40):37390-401. Epub 2001 Jul 26.

PMID:
11477076
[PubMed - indexed for MEDLINE]
Free Article
5.

GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner.

Yan W, Chen X.

J Biol Chem. 2006 Mar 24;281(12):7856-62. Epub 2006 Jan 30.

PMID:
16446369
[PubMed - indexed for MEDLINE]
Free Article
6.

Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.

Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR, Struhl K.

Mol Cell. 2006 Nov 17;24(4):593-602.

PMID:
17188034
[PubMed - indexed for MEDLINE]
Free Article
7.

Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach.

Birkaya B, Ortt K, Sinha S.

BMC Mol Biol. 2007 May 23;8:43.

PMID:
17521434
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.

Mondal N, Parvin JD.

Cancer Biol Ther. 2005 Apr;4(4):414-8. Epub 2005 Apr 21.

PMID:
15846087
[PubMed - indexed for MEDLINE]
Free Article
9.

p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.

Lefkimmiatis K, Caratozzolo MF, Merlo P, D'Erchia AM, Navarro B, Levrero M, Sbisa' E, Tullo A.

Cancer Res. 2009 Nov 15;69(22):8563-71. doi: 10.1158/0008-5472.CAN-09-0259. Epub 2009 Oct 27.

PMID:
19861536
[PubMed - indexed for MEDLINE]
Free Article
10.

p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.

Tan M, Bian J, Guan K, Sun Y.

Carcinogenesis. 2001 Feb;22(2):295-300.

PMID:
11181451
[PubMed - indexed for MEDLINE]
Free Article
11.

Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family.

Xu Y, Chen X.

J Biol Chem. 2006 Sep 8;281(36):26702-13. Epub 2006 Jul 10.

PMID:
16831876
[PubMed - indexed for MEDLINE]
Free Article
12.

Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.

Kato S, Shimada A, Osada M, Ikawa S, Obinata M, Nakagawara A, Kanamaru R, Ishioka C.

Cancer Res. 1999 Dec 1;59(23):5908-11.

PMID:
10606233
[PubMed - indexed for MEDLINE]
Free Article
13.

Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.

Muttray AF, Cox RL, Reinisch CL, Baldwin SA.

Mar Biotechnol (NY). 2007 Mar-Apr;9(2):217-30. Epub 2007 Jan 22.

PMID:
17242983
[PubMed - indexed for MEDLINE]
14.

Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence.

Djelloul S, Tarunina M, Barnouin K, Mackay A, Jat PS.

Oncogene. 2002 Feb 7;21(7):981-9.

PMID:
11850815
[PubMed - indexed for MEDLINE]
Free Article
15.

The fatty acid synthase gene is a conserved p53 family target from worm to human.

D'Erchia AM, Tullo A, Lefkimmiatis K, Saccone C, Sbisà E.

Cell Cycle. 2006 Apr;5(7):750-8. Epub 2006 Apr 1.

PMID:
16582625
[PubMed - indexed for MEDLINE]
Free Article
16.

The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.

Patel S, Bui TT, Drake AF, Fraternali F, Nikolova PV.

Biochemistry. 2008 Mar 11;47(10):3235-44. doi: 10.1021/bi7023207. Epub 2008 Feb 9. Erratum in: Biochemistry. 2008 May 20;47(20):5679-80.

PMID:
18260640
[PubMed - indexed for MEDLINE]
17.

Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.

Sbisà E, Mastropasqua G, Lefkimmiatis K, Caratozzolo MF, D'Erchia AM, Tullo A.

Cell Cycle. 2006 Jan;5(2):205-12. Epub 2006 Jan 16.

PMID:
16410722
[PubMed - indexed for MEDLINE]
Free Article
18.

Identification of vitamin D receptor as a target of p63.

Kommagani R, Caserta TM, Kadakia MP.

Oncogene. 2006 Jun 22;25(26):3745-51. Epub 2006 Feb 6.

PMID:
16462763
[PubMed - indexed for MEDLINE]
19.

p63: the phantom of the tumor suppressor.

Finlan LE, Hupp TR.

Cell Cycle. 2007 May 2;6(9):1062-71. Epub 2007 May 19. Review.

PMID:
17426453
[PubMed - indexed for MEDLINE]
Free Article
20.

Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.

Huang V, Lu X, Jiang Y, Wang JY.

BMC Biol. 2009 Jun 26;7:35. doi: 10.1186/1741-7007-7-35.

PMID:
19558638
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk